Go Pro
→ ALT SL: New Patent Reveals Elon Musk’s Next Breakthrough: M.A.G.I. (From Brownstone Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$0.69
$0.79
$0.38
▼
$2.45
$109.47M2.291.97 million shs727,387 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$1.74
+4.2%		$1.83
$1.60
▼
$4.67
$112.17M1.04542,479 shs510,751 shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$0.67
+0.3%		$0.76
$0.63
▼
$2.93
$31.47M0.78159,236 shs74,996 shs
Neuronetics, Inc. stock logo
STIM
Neuronetics
$1.97
+8.2%		$1.49
$0.80
▼
$4.85
$126.65M1.062.14 million shs758,446 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-4.51%-8.97%-13.27%+8.24%-62.09%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-0.60%-5.65%-10.70%-20.10%-37.69%
InspireMD, Inc. stock logo
NSPR
InspireMD
-2.10%-3.58%-1.41%-43.21%-72.54%
Neuronetics, Inc. stock logo
STIM
Neuronetics
-2.67%-5.70%+33.82%-6.19%-59.28%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$0.69
$0.79
$0.38
▼
$2.45
$109.47M2.291.97 million shs727,387 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$1.74
+4.2%		$1.83
$1.60
▼
$4.67
$112.17M1.04542,479 shs510,751 shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$0.67
+0.3%		$0.76
$0.63
▼
$2.93
$31.47M0.78159,236 shs74,996 shs
Neuronetics, Inc. stock logo
STIM
Neuronetics
$1.97
+8.2%		$1.49
$0.80
▼
$4.85
$126.65M1.062.14 million shs758,446 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-4.51%-8.97%-13.27%+8.24%-62.09%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-0.60%-5.65%-10.70%-20.10%-37.69%
InspireMD, Inc. stock logo
NSPR
InspireMD
-2.10%-3.58%-1.41%-43.21%-72.54%
Neuronetics, Inc. stock logo
STIM
Neuronetics
-2.67%-5.70%+33.82%-6.19%-59.28%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
2.50
Moderate Buy$5.12642.03% Upside
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
3.00
Buy$6.63280.75% Upside
InspireMD, Inc. stock logo
NSPR
InspireMD
3.00
Buy$4.50569.84% Upside
Neuronetics, Inc. stock logo
STIM
Neuronetics
2.50
Moderate Buy$4.00103.05% Upside

Current Analyst Ratings Breakdown

Latest NSPR, GUTS, STIM, and MBOT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/22/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
7/21/2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Outperform
7/20/2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$5.00
7/14/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
7/8/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/6/2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/1/2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
Craig Hallum logo
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$4.00
7/1/2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
Craig Hallum logo
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$4.00
6/18/2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
6/4/2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$8.00
6/3/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
Loop Capital logo
Loop Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$4.00
(Data available from 7/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$90K1,216.32N/AN/A$0.07 per share9.86
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/A$1.15 per shareN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
$10.85M2.90N/AN/A$1.83 per share0.37
Neuronetics, Inc. stock logo
STIM
Neuronetics
$151.64M0.90N/AN/A$0.38 per share5.18
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$140.95M-$1.29N/AN/AN/AN/A-4,053.15%-96.41%8/11/2026 (Estimated)
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$13.14M-$0.26N/AN/AN/AN/A-21.84%-20.71%8/11/2026 (Estimated)
InspireMD, Inc. stock logo
NSPR
InspireMD
-$19.92M-$0.73N/AN/AN/A-413.96%-69.42%-57.68%N/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$39M-$0.54N/AN/AN/A-24.48%-139.83%-27.13%8/11/2026 (Estimated)

Latest NSPR, GUTS, STIM, and MBOT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$0.15N/AN/AN/AN/AN/A
8/11/2026Q2 2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.08N/AN/AN/A$0.33 millionN/A
8/11/2026Q2 2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$0.11N/AN/AN/A$40.17 millionN/A
5/13/2026Q1 2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.08-$0.05+$0.03-$0.05$0.30 million$0.11 million
5/12/2026Q1 2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$0.17$0.06+$0.23$0.06N/AN/A
5/5/2026Q1 2026
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$0.17-$0.16+$0.01-$0.16$34.17 million$34.45 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
N/AN/AN/AN/AN/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
1.41
4.28
4.28
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
0.01
22.59
21.93
InspireMD, Inc. stock logo
NSPR
InspireMD
N/A
6.39
6.05
Neuronetics, Inc. stock logo
STIM
Neuronetics
3.59
1.67
1.50

Institutional Ownership

CompanyInstitutional Ownership
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
16.30%
InspireMD, Inc. stock logo
NSPR
InspireMD
44.78%
Neuronetics, Inc. stock logo
STIM
Neuronetics
53.59%

Insider Ownership

CompanyInsider Ownership
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
8.52%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
4.74%
InspireMD, Inc. stock logo
NSPR
InspireMD
29.72%
Neuronetics, Inc. stock logo
STIM
Neuronetics
8.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
102158.65 million145.13 millionN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2067.17 million63.98 millionOptionable
InspireMD, Inc. stock logo
NSPR
InspireMD
5046.84 million18.33 millionOptionable
Neuronetics, Inc. stock logo
STIM
Neuronetics
18069.59 million63.74 millionOptionable

Recent News About These Companies

Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call
July 28 at 9:00 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/28/3334245/0/en/Neuronetics-to-Report-Second-Quarter-2026-Financial-and-Operating-Results-and-Host-Conference-Call.html
Neuronetics Opens Greenbrook Mental Wellness Centers National Center of Excellence in Rockville, Maryland
July 28 at 8:50 AM  |  quiverquant.comQ
Neuronetics Announces Date for Second Quarter 2026 Financial and Operating Results Conference Call
July 28 at 8:50 AM  |  quiverquant.comQ
Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland
July 28 at 8:32 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/28/3334270/0/en/greenbrook-opens-national-center-of-excellence-for-advanced-interventional-psychiatry-in-rockville-maryland.html
Neuronetics (STIM) Expected to Post Quarterly Earnings on Tuesday
July 28 at 8:25 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/neuronetics-stim-expected-to-post-quarterly-earnings-on-tuesday-2026-07-28/
BTIG Research Begins Coverage on Neuronetics (NASDAQ:STIM)
July 22, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30913280
Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes
July 20, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/20/3330092/0/en/neuronetics-appoints-nir-naor-chief-financial-officer-announces-additional-management-changes.html
Why Is Neuronetics Stock Soaring Monday?
July 20, 2026  |  benzinga.comhttps://www.benzinga.com/analyst-stock-ratings/initiation/26/07/60561983/why-is-neuronetics-stock-soaring-monday?utm_source=snapi
Neuronetics (NASDAQ:STIM) Earns Buy Rating from Analysts at BTIG Research
July 20, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/neuronetics-nasdaqstim-earns-buy-rating-from-analysts-at-btig-research-2026-07-20/
Neuronetics: Top Line Growth, Low Valuation, But Gross Margin Struggles
July 18, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4923195-neuronetics-top-line-growth-low-valuation-but-gross-margin-struggles
Neuronetics (STIM) to Present at B. Riley Mind, Muscle & Vision Summit
July 14, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/neuronetics-stim-present-b-riley-180805585.html
Neuronetics (NASDAQ:STIM) Raised to Hold at Wall Street Zen
July 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/neuronetics-nasdaqstim-raised-to-hold-at-wall-street-zen-2026-07-12/
Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026
July 6, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/06/3322415/0/en/neuronetics-to-participate-in-a-panel-discussion-at-b-riley-securities-mind-muscle-vision-summit-on-july-16-2026.html
Neuronetics Posts Q1 Revenue Growth and Expanded TMS Coverage
June 25, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/STIM-Q/pressreleases/1740867/neuronetics-posts-q1-revenue-growth-and-expanded-tms-coverage/
Neuronetics Appoints Robert Greene as Senior Vice President Sales
June 2, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/02/3305620/0/en/neuronetics-appoints-robert-greene-as-senior-vice-president-sales.html
Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026
June 2, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/02/3305196/0/en/neuronetics-highlights-continued-advancements-in-tms-research-at-ctmss-2026.html
Neuronetics Shareholders Approve Directors, Auditor and Equity Plan
May 29, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/neuronetics-shareholders-approve-directors-auditor-and-equity-plan?utm_source=marketbeat.com&utm_medium=referral
Neuronetics Extends Interim Financial Leadership Through Amended Agreement
May 22, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/neuronetics-extends-interim-financial-leadership-through-amended-agreement?utm_source=marketbeat.com&utm_medium=referral
Jorey Chernett Buys 100,000 Shares of Neuronetics (NASDAQ:STIM) Stock
May 21, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-stim-insider-buying-and-selling-2026-05-21/
Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment
May 14, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/14/3294949/0/en/neuronetics-and-ant-neuro-announce-strategic-collaboration-to-integrate-neuronavigation-with-neurostar-tms-treatment.html
Jorey Chernett Purchases 475,000 Shares of Neuronetics (NASDAQ:STIM) Stock
May 14, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-stim-insider-buying-and-selling-2026-05-14/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
A Patriot missile launcher and soldier on an airbase tarmac as an F-35 fighter jet flies overhead at sunset.
RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
By Dan Schmidt | July 26, 2026
General Mills logo displayed on an illuminated sign in a modern corporate office lobby.
General Mills Is a 5-Star Turnaround Play for Buy and Hold Investors
By Thomas Hughes | July 2, 2026
SK hynix logo above a robotic arm placing memory chips on a wafer in a server data center.
Why SK hynix Could Be the Best AI Chip Stock to Buy Now
By Thomas Hughes | July 29, 2026
Corona Extra, Modelo Especial, and Pacifico beer bottles on a table beside a Constellation Brands logo sign.
Constellation Brands: Beer Growth and Buybacks Mask Stock's Slump
By Chris Markoch | July 9, 2026
Framed houses under construction with workers, illustrating homebuilding slowdown and weak demand.
D.R. Horton Is Defying the Housing Gloom
By Peter Frank | July 4, 2026
Fractyl Health stock logo

Fractyl Health NASDAQ:GUTS

$0.69 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$0.70 +0.01 (+1.59%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

Microbot Medical stock logo

Microbot Medical NASDAQ:MBOT

$1.74 +0.07 (+4.19%)
Closing price 04:00 PM Eastern
Extended Trading
$1.74 0.00 (-0.29%)
As of 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

InspireMD stock logo

InspireMD NYSE:NSPR

$0.67 +0.00 (+0.25%)
Closing price 03:59 PM Eastern
Extended Trading
$0.67 +0.00 (+0.18%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Neuronetics stock logo

Neuronetics NASDAQ:STIM

$1.97 +0.15 (+8.24%)
Closing price 04:00 PM Eastern
Extended Trading
$1.96 -0.01 (-0.51%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas